Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Daiichi Pharmaceutical Co., Ltd.

This section introduces our corporate information, philanthropic activities, environmental reports and such


Contact Details:
14-10, Nihonbashi 3-chome
Chuo-ku
Tokyo
103-8234
Japan
Tel:81-3-3272-0611
Fax:81-3-3272-7348
Email:presdrug2@daiichipharm.co.jp
WWW:

www.daiichipharm.co.jp/




Press Releases on Daiichi Pharmaceutical Co., Ltd.:

BioPortfolio Logo
YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 11th November, 2009 YM BioSciences Inc.
MISSISSAUGA, ON, Nov. 11 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of
Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b 2nd September, 2008 Daiichi Sankyo
MUNICH, Germany, Sept. 2 /PRNewswire-FirstCall/ -- Data presented today at the Annual Congress of the European Society of Cardiology showed that the investigational oral Factor Xa inhibitor DU

BioNews Results for Daiichi Pharmaceutical Co., Ltd.:

YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS
CNW Telbec:  Nov 12 2009 3:56AM Matching: daiichi pharmaceutical
Announcing the 9th Annual ePharma Summit February 8-10, 2010 Hyatt Regency at PennEURs Landing, Philadelphia
Pharma Live:  Nov 12 2009 12:04AM Matching: daiichi pharmaceutical
Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research
Earthtimes.org:  Nov 12 2009 7:17AM Matching: daiichi pharmaceutical
University Of Minnesota Medical School / Drug maker freebies may be
TwinCities.com:  Nov 9 2009 11:08PM Matching: daiichi pharmaceutical
University Of Minnesota Medical School / Drug maker freebies may be banned
TwinCities.com:  Nov 9 2009 9:10AM Matching: daiichi pharmaceutical
Promote your company here: BioNewsCast - Press Release Distribution

View more Daiichi Pharmaceutical Co., Ltd. news.

Daiichi Pharmaceutical Co., Ltd. Patents:

US Patent No.Title
6756378 VLA-4 inhibitor compounds
7056917 Drug efflux pump inhibitor
7074837 Processes for preparation of bicyclic compounds and intermediates therefor
7087778 Process for producing benzoxazine derivative and production intermediate thereof
7115568 Methods using TCF II

View more Daiichi Pharmaceutical Co., Ltd. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 506 times since April 2007, the link to the organisation's website has been followed 68 times

Recent Search Terms used to find this page: Daiichi Pharmaceutical Co Ltd | Daiichi Pharmaceutical Co. Ltd | Daiichi Pharmaceutical Co. Ltd. | Daiichi Pharmaceutical Co Ltd. | daiichi pharmaceutical co ltd | Daiichi Pharmaceutical Co. Ltd | Daiichi Pharmaceutical Co Ltd | daiichi pharmaceutical company | .

Search for more companies in Chuo-ku

Search for more companies in Tokyo



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Daiichi Pharmaceutical Co., Ltd.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.